Before a drug can be used to treat a disease, it must go through a lengthy and expensive trial process to prove both safety and effectiveness. By repurposing already-approved drugs, researchers can cut out the time and expense ...
Jan 12, 2024
0
12
A research team led by the Nagoya University Graduate School of Medicine has discovered that the stromal cell-derived factor 4 (SDF-4) protein is a reliable cancer marker. As simple blood tests accurately detect the protein, ...
Nov 10, 2023
0
69
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often ...
Sep 28, 2023
0
18
Pancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients, making long-term survival possible.
Aug 28, 2023
0
5
From 2010 to 2019, the incidence rates of early-onset cancers increased, with gastrointestinal cancers having the fastest-growing incidence rates, according to a study published online Aug. 16 in JAMA Network Open.
Aug 19, 2023
0
2
Doctors have long stressed the importance of maintaining a healthy weight for improving overall health, but a large new study also suggests it could also reduce future gastrointestinal cancer (GI) risk.
May 10, 2023
0
48
Gastric cancer is one of the most common cancers worldwide. A new invention by researchers from the National University of Singapore (NUS) could help improve the treatment of this cancer by enhancing the precision of radiotherapy, ...
Apr 14, 2023
0
14
Through the ESPRESSO cohort, researchers from Massachusetts General Hospital, Boston, University of Newcastle, Australia, University of Washington, Seattle, and Karolinska Institutet examined the risk of cancer among 75,000 ...
Oct 28, 2022
0
2
Research led by Case Western Reserve University has identified a promising path to developing therapies to treat esophageal tumors––a form of cancer that not only is among the most deadly, but also has been occurring ...
Sep 7, 2022
0
6
UCLA researchers report a step forward in the development of an "off-the-shelf" cell therapy that could reduce the severity of graft-versus-host disease in people receiving donor bone marrow transplants for the treatment ...
Sep 6, 2022
0
57
